There is accumulating evidence that the use of inhaled corticosteroids is associated with a
dose-related reduction in bone mineral density. Whether this translates to an increase in …

Objective: To examine whether bone mass is reduced in prepubertal, asthmatics receiving
high doses of inhaled corticosteroids. Methodology: A cross‐sectional comparison of lumbar …

Oral corticosteroids have adverse effects on bone density and metabolism. With the
increased use of inhaled corticosteroids together with the use of higher doses for the …

Abstract Treatment with systemic corticosteroids is known to increase the risk of fractures but
little is known of the fracture risks associated with inhaled corticosteroids. A retrospective …

Bone mass and biochemical bone markers were prospectively studied in 33 patients with
chronic obstructive pulmonary disease treated for 1 year with inhaled beclomethasone 200 …

Objective: Inhaled corticosteroids have become a key element in the maintenance treatment
of bronchial asthma. Recent studies have shown that administration of inhaled …

We assessed the association between long-term inhaled corticosteroid (ICS) use and bone
mineral density (BMD) in older women with chronic respiratory disease. Women with> 50 …

With improvements in techniques for measuring bone mass, interest and concern have
increased about the effects of asthma therapies, particularly corticosteroids, on bone mineral …

Long term usage of systemic steroids is associated with multiple side effects. One of the
major morbidities is due to its effect on bone metabolism leading to bone loss and resulting …

Introduction Oral glucocorticoid therapy reduces bone mineral density (BMD) and increases
fracture risk. It is uncertain whether inhaled glucocorticoids, the most commonly used long …